| Autor: |
Barge, Sagar, Deka, Barsha, Kashyap, Bhaswati, Bharadwaj, Simanta, Kandimalla, Raghuram, Ghosh, Aparajita, Dutta, Partha Pratim, Samanta, Suman Kumar, Manna, Prasenjit, Borah, Jagat C., Talukdar, Narayan Chandra |
| Zdroj: |
Phytotherapy Research; Dec2021, Vol. 35 Issue 12, p6990-7003, 14p |
| Abstrakt: |
Metabolic disturbances in different tissue cells and obesity are caused by excessive calorie intake, and medicinal plants are potential sources of phytochemicals for combating these health problems. This study investigated the role of methanolic extract of the folklore medicinal plant Lysimachia candida (LCM) and its phytochemical, astragalin, in managing obesity in vivo and in vitro. Administration of LCM (200 mg/kg/body weight) daily for 140 days significantly decreased both the body weight gain (15.66%) and blood triglyceride and free fatty acid levels in high‐fat‐diet‐fed male Wistar rats but caused no substantial change in leptin and adiponectin levels. The protein expression of adipogenic transcription factors in visceral adipose tissue was significantly reduced. Further, the 3T3‐L1 cell‐based assay revealed that the butanol fraction of LCM and its isolated compound, astragalin, exhibited antiadipogenic activity through downregulating adipogenic transcription factors and regulatory proteins. Molecular docking studies were performed to depict the possible binding patterns of astragalin to adipogenesis proteins. Overall, we show the potential antiobesity effects of L. candida and its bioactive compound, astragalin, and suggest clinical studies with LCM and astragalin. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text